Woodline Partners »

Candel Therapeutics shares owned by Woodline Partners

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Woodline Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $768k 157k 4.90
2021-12-31 $782k 100k 7.82
2021-09-30 $1.1M 100k 10.84